Search

everythinglearnresearchcommunity

for

Search:↓

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Platelet-Rich Fibrin shows promise in medicine and dentistry, but more research is needed to standardize its use.

PDF2 senses specific lipids and regulates root growth and gene expression in Arabidopsis.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Targeting FGF5 could help treat prostate cancer.

FFA patients have fewer melanocytes and thinner skin compared to others.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

EDM is better for isolating and growing human foreskin fibroblasts, and PPP helps repair UVB damage.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

PDGF-BB helps young melanocytes grow but stops mature ones from growing, and it makes melanocytes more specialized.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Electric pulses can effectively activate platelets and release growth factors, offering a better alternative to traditional methods.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

Photobiomodulation effectively improves skin and hair conditions with minimal side effects.

Unified regulations and ethical guidelines are needed for fair use of forensic DNA phenotyping.

Pneumatic Skin Flattening (PSF) significantly reduces pain during laser and IPL hair removal.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

The new system helps detect and track early female hair loss better.